Theratechnologies Inc. (TSX:TH)
Canada
· Delayed Price · Currency is CAD 3.870
-0.040 (-1.02%)
Apr 25, 2025, 3:59 PM EDT
Theratechnologies Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2015 - 2019 |
| Revenue | 88.67 | 85.87 | 81.76 | 80.06 | 69.82 | 66.05 | Upgrade
|
| Revenue Growth (YoY) | 13.52% | 5.02% | 2.13% | 14.66% | 5.71% | 4.49% | Upgrade
|
| Cost of Revenue | 18.65 | 20.45 | 19.64 | 23.84 | 18.38 | 22.02 | Upgrade
|
| Gross Profit | 70.02 | 65.42 | 62.13 | 56.22 | 51.45 | 44.03 | Upgrade
|
| Selling, General & Admin | 40.07 | 38.83 | 39.29 | 47.54 | 40.35 | 39.09 | Upgrade
|
| Research & Development | 16.19 | 16.97 | 28.99 | 36.94 | 28.27 | 18.02 | Upgrade
|
| Operating Expenses | 57.7 | 57.24 | 70.79 | 96.13 | 76.68 | 61.99 | Upgrade
|
| Operating Income | 12.32 | 8.17 | -8.66 | -39.91 | -25.24 | -17.96 | Upgrade
|
| Interest Expense | -8.9 | -10.42 | -11.32 | -6.5 | -5.66 | -5.36 | Upgrade
|
| Interest & Investment Income | 1.08 | 1.49 | 0.77 | 0.32 | 0.2 | 0.72 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.49 | 0.46 | 1.1 | -1.03 | -0.93 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.17 | -0.11 | -0.04 | -0.04 | -0.03 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | 4.81 | -0.4 | -18.15 | -47.15 | -31.66 | -22.65 | Upgrade
|
| Merger & Restructuring Charges | - | - | -1.96 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.45 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | -5.87 | -5.9 | -3.42 | 0.36 | - | - | Upgrade
|
| Pretax Income | -1.51 | -6.3 | -23.54 | -46.79 | -31.66 | -22.65 | Upgrade
|
| Income Tax Expense | 2.2 | 2.01 | 0.42 | 0.44 | 0.06 | 0.02 | Upgrade
|
| Net Income | -3.71 | -8.31 | -23.96 | -47.24 | -31.73 | -22.67 | Upgrade
|
| Net Income to Common | -3.71 | -8.31 | -23.96 | -47.24 | -31.73 | -22.67 | Upgrade
|
| Shares Outstanding (Basic) | 49 | 49 | 26 | 24 | 23 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 49 | 49 | 26 | 24 | 23 | 19 | Upgrade
|
| Shares Change (YoY) | 51.31% | 87.46% | 10.58% | 3.14% | 19.95% | 0.08% | Upgrade
|
| EPS (Basic) | -0.08 | -0.17 | -0.91 | -1.98 | -1.37 | -1.18 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.17 | -0.91 | -1.98 | -1.37 | -1.18 | Upgrade
|
| Free Cash Flow | -5.66 | 2.38 | -6 | -15.68 | -17.63 | -13.59 | Upgrade
|
| Free Cash Flow Per Share | -0.12 | 0.05 | -0.23 | -0.66 | -0.76 | -0.71 | Upgrade
|
| Gross Margin | 78.97% | 76.19% | 75.99% | 70.22% | 73.68% | 66.66% | Upgrade
|
| Operating Margin | 13.89% | 9.52% | -10.60% | -49.85% | -36.14% | -27.19% | Upgrade
|
| Profit Margin | -4.18% | -9.67% | -29.30% | -59.00% | -45.44% | -34.32% | Upgrade
|
| Free Cash Flow Margin | -6.38% | 2.77% | -7.33% | -19.58% | -25.25% | -20.57% | Upgrade
|
| EBITDA | 14.72 | 10.6 | -5.7 | -27.87 | -16.94 | -9.88 | Upgrade
|
| EBITDA Margin | 16.60% | 12.34% | -6.97% | -34.81% | -24.26% | -14.95% | Upgrade
|
| D&A For EBITDA | 2.41 | 2.42 | 2.96 | 12.04 | 8.3 | 8.08 | Upgrade
|
| EBIT | 12.32 | 8.17 | -8.66 | -39.91 | -25.24 | -17.96 | Upgrade
|
| EBIT Margin | 13.89% | 9.52% | -10.60% | -49.85% | -36.14% | -27.19% | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.